Clinical and pharmacokinetic study with a lipidic prodrug of mitomycin-c entrapped in liposomes in metastatic colorectal cancer patients

被引：0
|
作者：
Gabizon, Alberto A. [1 ]
Tahover, Esther [1 ]
Perets, Ruth [2 ]
Golan, Talia [3 ]
Geva, Ravit [4 ]
Amitay, Yasmine [5 ]
Shmeeda, Hilary [1 ]
Ohana, Patricia [1 ]
机构：
[1] Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Rambam Hlth Care Campus, Haifa, Israel
[3] Sheba Med Ctr, Ramat Gan, Israel
[4] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[5] Lipomedix Pharmaceut, Jerusalem, Israel
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-CT054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT054
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pegylated Liposomal Mitomycin C Lipidic Prodrug in Combination With External Beam Radiation Therapy in Patients With Advanced Cancer: A Phase 1B Study
    Sapir, Eli
    Pfeffer, Raphael
    Wygoda, Marc
    Purim, Ofer
    Levy, Adi
    Corn, Benjamin
    Amitay, Yasmine
    Ohana, Patricia
    Gabizon, Alberto
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (01): : 64 - 73
  • [42] A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
    Allegrini, G.
    Falcone, A.
    Fioravanti, A.
    Barletta, M. T.
    Orlandi, P.
    Loupakis, F.
    Cerri, E.
    Masi, G.
    Di Paolo, A.
    Kerbel, R. S.
    Danesi, R.
    Del Tacca, M.
    Bocci, G.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1312 - 1319
  • [43] A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
    G Allegrini
    A Falcone
    A Fioravanti
    M T Barletta
    P Orlandi
    F Loupakis
    E Cerri
    G Masi
    A Di Paolo
    R S Kerbel
    R Danesi
    M Del Tacca
    G Bocci
    British Journal of Cancer, 2008, 98 : 1312 - 1319
  • [44] Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
    G Chong
    D Cunningham
    British Journal of Cancer, 2006, 94 : 937 - 937
  • [45] Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
    Chong, G
    Cunningham, D
    BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 937 - 937
  • [46] REGIONAL ARTERIAL INFUSION OF MITOMYCIN-C IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    TSENG, MH
    MITTELMAN, A
    CLINICAL RESEARCH, 1981, 29 (02): : A442 - A442
  • [47] ADJUVANT PERIOPERATIVE HEPATIC ARTERIAL MITOMYCIN-C AND FLOXURIDINE COMBINED WITH SURGICAL RESECTION OF METASTATIC COLORECTAL-CANCER IN THE LIVER
    PATT, YZ
    MCBRIDE, CM
    AMES, FC
    CLAGHORN, LJ
    CLEARY, KR
    BODDIE, AW
    CHARNSANGAVEJ, C
    MAVLIGIT, GM
    CANCER, 1987, 59 (05) : 867 - 873
  • [48] MITOMYCIN-C IN THE TREATMENT OF METASTATIC PROSTATE-CANCER - REPORT ON AN EORTC PHASE-II STUDY
    JONES, WG
    FOSSA, SD
    BONO, AV
    CROLES, JJ
    STOTER, G
    DEPAUW, M
    SYLVESTER, R
    WORLD JOURNAL OF UROLOGY, 1986, 4 (03) : 182 - 185
  • [49] A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer
    Kim, Jung Han
    Kim, Hyeong Su
    Choi, Dae Ro
    Jang, Geundoo
    Kwon, Jung Hye
    Kim, Ho Young
    Jung, Joo Young
    Kim, Hyo Jung
    Song, Hun Ho
    Shin, Yun Ho
    Jung, So Young
    Kim, Byung Chun
    Zang, Dae Young
    ONCOLOGY LETTERS, 2011, 2 (06) : 1253 - 1256
  • [50] The combination of Raltitrexed (tomudex) and Mitomycin-C in the treatment of advanced colorectal cancer: A phase-II-study
    Michels, JE
    Harvey, M
    Darby, A
    Iveson, AM
    Nokes, L
    Iveson, TJ
    BRITISH JOURNAL OF CANCER, 2000, 83 : 46 - 46
12345